236 related articles for article (PubMed ID: 32521719)
1. Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis.
Gatta V; Mengod G; Reale M; Tata AM
Biomedicines; 2020 Jun; 8(6):. PubMed ID: 32521719
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phase.
Di Pinto G; Di Bari M; Martin-Alvarez R; Sperduti S; Serrano-Acedo S; Gatta V; Tata AM; Mengod G
Eur J Neurosci; 2018 Sep; 48(5):2165-2181. PubMed ID: 30144326
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis.
Di Bari M; Di Pinto G; Reale M; Mengod G; Tata AM
Cent Nerv Syst Agents Med Chem; 2017; 17(2):109-115. PubMed ID: 27550615
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.
Di Bari M; Reale M; Di Nicola M; Orlando V; Galizia S; Porfilio I; Costantini E; D'Angelo C; Ruggieri S; Biagioni S; Gasperini C; Tata AM
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916909
[TBL] [Abstract][Full Text] [Related]
5. Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107.
Mizrachi T; Marsha O; Brusin K; Ben-David Y; Thakur GA; Vaknin-Dembinsky A; Treinin M; Brenner T
J Neuroinflammation; 2021 Apr; 18(1):99. PubMed ID: 33902624
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
Reale M; Costantini E; Di Nicola M; D'Angelo C; Franchi S; D'Aurora M; Di Bari M; Orlando V; Galizia S; Ruggieri S; Stuppia L; Gasperini C; Tata AM; Gatta V
Sci Rep; 2018 Jan; 8(1):1319. PubMed ID: 29358722
[TBL] [Abstract][Full Text] [Related]
8. Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Liu Q; Whiteaker P; Morley BJ; Shi FD; Lukas RJ
Front Cell Neurosci; 2017; 11():287. PubMed ID: 29018331
[TBL] [Abstract][Full Text] [Related]
9. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
Reale M; Di Bari M; Di Nicola M; D'Angelo C; De Angelis F; Velluto L; Tata AM
Int Immunopharmacol; 2015 Nov; 29(1):152-7. PubMed ID: 26209886
[TBL] [Abstract][Full Text] [Related]
11. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
DiSano KD; Linzey MR; Royce DB; Pachner AR; Gilli F
J Neuroinflammation; 2019 May; 16(1):109. PubMed ID: 31118079
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.
Jiang W; Li D; Han R; Zhang C; Jin WN; Wood K; Liu Q; Shi FD; Hao J
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6202-E6211. PubMed ID: 28696300
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain.
Takano C; Takano T; Masumura M; Nakamura R; Koda S; Bochimoto H; Yoshida S; Bando Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175866
[TBL] [Abstract][Full Text] [Related]
14. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
15. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
16. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
17. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
18. Role of autophagy in the pathogenesis of multiple sclerosis.
Liang P; Le W
Neurosci Bull; 2015 Aug; 31(4):435-44. PubMed ID: 26254059
[TBL] [Abstract][Full Text] [Related]
19. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler's Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE.
Moriguchi K; Nakamura Y; Park AM; Sato F; Kuwahara M; Khadka S; Omura S; Ahmad I; Kusunoki S; Tsunoda I
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629117
[TBL] [Abstract][Full Text] [Related]
20. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
